Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05228886 · ClinicalTrials.gov registry record · NA

The SINCERE Intervention to Address COVID-19 Health Disparities

A NA study of COVID-19 and Social Determinants of Health, sponsored by Andrea Wallace.

Recruiting
Registry status
NA
Development phase
1,500
Enrollment target
1
Study location

NCT05228886 is a NA study of COVID-19 and Social Determinants of Health that is actively recruiting participants, run by Andrea Wallace. The registered enrollment target is 1,500 participants, below the 55,207-participant average among 203 other COVID-19 trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05228886, a NA study of COVID-19 and Social Determinants of Health, is actively recruiting participants, sponsored by Andrea Wallace.

RECRUITING
Registry status
NA
Development phase
1,500 participants
Enrollment target
1
Study location

Study Summary

The goal of this real world efficacy study is to understand the benefit of universal social needs screening, community-based service referrals, and telephonic follow-up as a scalable strategy for preventing COVID-19 transmission, and for addressing the secondary health effects of the social, behavioral, and economic changes following the COVID-19 pandemic. With statewide community service providers, existing health information technology, and piloted methods, we seek to determine the effectiveness of universal social needs screening and community service referrals - the SINCERE intervention - in improving health outcomes of COVID-19 vulnerable and socioeconomically disadvantaged populations and whether intensive follow-up and collaborative goal-setting helps overcome barriers to community service use by patients seen in the emergency department and seeking COVID testing at community-based and mobile clinic locations.

Interventions

  • OTHER Standard of Care
  • BEHAVIORAL SINCERE
  • BEHAVIORAL Scheduled Follow-Up

Study Locations (1)

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 2021-09-27
Est. Completion 2026-03-31
Phase NA

Sponsor

Andrea Wallace

4 total trials

What the Registry Record Tells You About NCT05228886

The ClinicalTrials.gov registry entry for NCT05228886 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,207-participant average among 203 other COVID-19 trials with a reported enrollment target (97% lower). The listed sponsor is Andrea Wallace, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with COVID-19 appearing as the primary indexed condition, and to 3 interventions - of which Standard of Care is the first listed.

NCT05228886 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT05228886 about?

NCT05228886 is a clinical study titled "The SINCERE Intervention to Address COVID-19 Health Disparities". The goal of this real world efficacy study is to understand the benefit of universal social needs screening, community-based service referrals, and telephonic follow-up as a scalable strategy for preventing COVID-19 transmission, and for addressing the secondary health effects of the social, behavio...

What is the current status of trial NCT05228886?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,500 participants. The study started on 2021-09-27. Estimated completion is 2026-03-31.

What conditions does trial NCT05228886 study?

This clinical trial studies the following conditions: COVID-19, Social Determinants of Health, Vulnerable Populations.

What interventions are being tested in trial NCT05228886?

The interventions under investigation include: Standard of Care (OTHER), SINCERE (BEHAVIORAL), Scheduled Follow-Up (BEHAVIORAL).

Who is sponsoring clinical trial NCT05228886?

This trial is sponsored by Andrea Wallace, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05228886 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.